are the medicines that make use of the body’s own immune system to identify, locate and eliminate cells which are responsible for the target disease. These types of have been successful in attracting the attention of researchers worldwide owing to their characteristic features such as fewer side effects and high efficacy in curing certain diseases which were previously untreatable. These drugs show promising efficacy for the treatment of certain diseases for which no equally effective treatment is available. Antibody drugs are primarily used for the treatment of diseases such as central nervous system ailments, allergic diseases, cancer, and infection. This report is focused on identifying market size for anti-body drugs. Increasing medical infrastructure in emerging economies and developing medical tourism in these countries along with increasing R&D activities in the field of anti-body drugs is expected to drive the demand for anti-body drugs globally.
This report identifies the
anti-body drugs market
size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to anti-body drugs market.
Globally North America is the largest market for anti-body drugs in 2015 followed by Europe and Asia-Pacific as second and third largest regional markets respectively. However anti-body market in Asia-Pacific region is expected to grow fastest due to increasing demand of anti-body drugs in the region due to developing medical infrastructure in the region which is also resulting into growing medical infrastructure in the region.
- On the basis of diseases cured by anti-body drug type this report classified as follows covering all major types of diseases cured by these drugs: Central nervous system ailment, Allergic diseases, Cancer, Infections and Others
- This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for anti-body drugs in each of the region.
This report identifies all the major companies operating in the global anti-body drugs market. Some of the major companies’ profiles in detail are as follows:
- Abbott Laboratories
- Bayer HealthCare AG
- Eli Lilly and Co.
- UCB Company
- Merck & Co.
- Johnson & Johnson